rhodioloside has been researched along with Alloxan Diabetes in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 11 (68.75) | 2.80 |
| Authors | Studies |
|---|---|
| Han, J; He, Y; Huang, S; Kasim, V; Liu, C; Marcelina, O; Miyagishi, M; Nugrahaningrum, DA; Wang, G; Wu, S; Zou, M | 1 |
| Ding, L; Jiang, X; Peng, Z; Qiu, L; Xia, X; Yao, F; Zheng, W | 1 |
| Bao, Y; Pei, D; Piao, M; Tian, S; Xu, D; Zhang, J | 1 |
| Chen, SY; Feng, TH; Hao, DD; Miao, HX; Shang, J; Shi, J; Wan, S; Wang, SY; Zhao, Q; Zhou, CH | 1 |
| Chen, L; Chen, S; Gao, Y; Guo, X; Li, X; Wang, Q; Yan, S; Zhang, Y; Zheng, T; Zhou, J | 1 |
| Bi, J; Liu, W; Liu, X; Lv, P; Wang, X; Wang, Y; Yu, H; Yu, S; Zhang, T; Zhao, L; Zuo, Z | 1 |
| Li, J; Liu, A; Liu, W; Liu, X; Wang, Y; Yu, H; Yu, S; Zuo, Z | 1 |
| Fu, C; Huang, Y; Liu, WQ; Liu, XZ; Lv, P; Meng, L; Wang, XB; Wang, XH; Wang, YF; Yang, Q; Zhao, LP; Zheng, DY; Zuo, ZF | 1 |
| Jiang, YP; Liu, N; Ma, L; Niu, JG; Sun, T; Yang, JM; Ye, RJ; Yu, JQ; Zhang, WJ; Zheng, P | 1 |
| Bian, F; Chen, L; Hao, X; Lei, P; Lu, W; Ma, W; Wang, Q; Zhang, L; Zhang, Y; Zhao, Y; Zheng, T | 1 |
| Jin, S; Li, Y; Liu, SL; Wei, X; Yang, XY; Zhao, Y | 1 |
| Bai, YG; Dai, ZJ; Liu, M; Ma, YG; Wang, JW; Xie, MJ | 1 |
| Dong, H; Hao, X; Yuan, J | 1 |
| Ariyanti, AD; Kasim, V; Marcelina, O; Nugrahaningrum, DA; Wang, G; Wu, S; Zhang, J | 1 |
| Bai, X; Bian, F; Chen, X; Chi, J; Jin, S; Li, W; Wu, D; Wu, G; Xing, S; Yang, X; Zhang, Y; Zheng, T | 1 |
| Gong, J; Li, F; Meng, X; Peng, Y; Tang, H; Xiao, F | 1 |
16 other study(ies) available for rhodioloside and Alloxan Diabetes
| Article | Year |
|---|---|
Discovery of Salidroside-Derivated Glycoside Analogues as Novel Angiogenesis Agents to Treat Diabetic Hind Limb Ischemia.
Topics: Angiogenesis Inducing Agents; Animals; Diabetes Mellitus, Experimental; Glucosides; Glycosides; Hindlimb; Ischemia; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Phenols; Rats; Rats, Sprague-Dawley | 2022 |
Long-Term Oral Administration of Salidroside Alleviates Diabetic Retinopathy in db/db Mice.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glucosides; Mice; Phenols | 2022 |
Protective effect of salidroside on streptozotocin-induced diabetic nephropathy by inhibiting oxidative stress and inflammation in rats via the Akt/GSK-3β signalling pathway.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glucosides; Glycogen Synthase Kinase 3 beta; Inflammation; Male; Oxidative Stress; Phenols; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Streptozocin | 2022 |
Gut microbiota profiling revealed the regulating effects of salidroside on iron metabolism in diabetic mice.
Topics: Animals; Biomarkers; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Gastrointestinal Microbiome; Glucosides; Iron; Mice; Phenols; RNA, Ribosomal, 16S | 2022 |
Salidroside protects pancreatic β-cells against pyroptosis by regulating the NLRP3/GSDMD pathway in diabetic conditions.
Topics: AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Experimental; Inflammasomes; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis; Rats; Reactive Oxygen Species | 2023 |
Salidroside Alleviates Diabetic Cognitive Dysfunction Via B3galt2/F3/Contactin Signaling Pathway in Mice.
Topics: Animals; Cognitive Dysfunction; Contactin 1; Contactins; Diabetes Mellitus, Experimental; Mice; Mice, Inbred C57BL; Signal Transduction | 2023 |
Salidroside Inhibits Ganglion Cell Apoptosis by Suppressing the Müller Cell Inflammatory Response in Diabetic Retinopathy.
Topics: Animals; Apoptosis; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Eosine Yellowish-(YS); Ependymoglial Cells; Glial Fibrillary Acidic Protein; Hematoxylin; Mice | 2023 |
Neuroprotective effect of salidroside on hippocampal neurons in diabetic mice via PI3K/Akt/GSK-3β signaling pathway.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Brain Diseases; Caspase 3; Diabetes Mellitus, Experimental; Glycogen Synthase Kinase 3 beta; Hippocampus; Hypoglycemia; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Signal Transduction | 2023 |
Protective effects of Salidroside on spermatogenesis in streptozotocin induced type-1 diabetic male mice by inhibiting oxidative stress mediated blood-testis barrier damage.
Topics: Animals; Antioxidants; Blood-Testis Barrier; Catalase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucosides; Glutathione; Male; Malondialdehyde; Mice; Oxidative Stress; Phenols; Protective Agents; Reactive Oxygen Species; Sperm Count; Spermatogenesis; Spermatozoa; Streptozocin; Superoxide Dismutase; Testis | 2020 |
Salidroside alleviates diabetic neuropathic pain through regulation of the AMPK-NLRP3 inflammasome axis.
Topics: AMP-Activated Protein Kinases; Analgesics; Animals; Blood Glucose; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Ganglia, Spinal; Glucosides; Hypoglycemic Agents; Inflammasomes; Insulin Resistance; Male; Neuralgia; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Pain Threshold; Phenols; Rats, Sprague-Dawley; Signal Transduction | 2021 |
Salidroside protects cardiac function in mice with diabetic cardiomyopathy via activation of mitochondrial biogenesis and SIRT3.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Glucosides; Mice; Mitochondria; Myocytes, Cardiac; Organelle Biogenesis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phenols; Rats; Sirtuin 3 | 2021 |
Salidroside contributes to reducing blood pressure and alleviating cerebrovascular contractile activity in diabetic Goto-Kakizaki Rats by inhibition of L-type calcium channel in smooth muscle cells.
Topics: Animals; Blood Glucose; Blood Pressure; Calcium Channels, L-Type; Cells, Cultured; Cerebral Arteries; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Gene Expression Regulation; Glucosides; Hypoglycemic Agents; Male; Muscle Contraction; Muscle, Smooth, Vascular; Phenols; Rats, Inbred WKY; RNA, Messenger; Vasodilation | 2017 |
Salidroside prevents diabetes‑induced cognitive impairment via regulating the Rho pathway.
Topics: Animals; Apoptosis; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Gene Expression Regulation; Glucosides; Male; Oxidative Stress; Phenols; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Signal Transduction | 2019 |
Salidroside-Pretreated Mesenchymal Stem Cells Enhance Diabetic Wound Healing by Promoting Paracrine Function and Survival of Mesenchymal Stem Cells Under Hyperglycemia.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Glucosides; Hyperglycemia; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Paracrine Communication; Phenols; Survival Rate; Wound Healing | 2019 |
Salidroside ameliorates insulin resistance through activation of a mitochondria-associated AMPK/PI3K/Akt/GSK3β pathway.
Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Glucosides; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hepatocytes; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; Oxygen Consumption; Pancreas; Phenols; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt | 2015 |
Protective effect of salidroside from Rhodiolae Radix on diabetes-induced oxidative stress in mice.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Fasting; Glucosides; Insulin; Kidney; Lipids; Liver; Male; Malondialdehyde; Mice; Oxidative Stress; Phenols; Protective Agents; Rhodiola | 2011 |